Safety and Efficacy of Matrix Pro for Eyebrow Lift and Lift of Submental/Neck Laxity
NCT06640998 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2024-10-17
Summary
Prospective, non-randomized, multi-center, pivotal clinical trial
Conditions
- Laxity; Skin
Interventions
- DEVICE
-
Matrix Pro
Study subjects received up to three (3) study treatments with the Matrix Pro applicator
Sponsors & Collaborators
-
Candela Corporation
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-09-09
- Primary Completion
- 2027-09-30
- Completion
- 2028-09-30
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Lifting and Tightening of the Face and Neck Utilizing the Ulthera® System
NCT01368874 ·Status: COMPLETED ·Phase: NA
-
Treatment of the Face and Neck With Lower Ulthera System Energy Settings
NCT01713998 ·Status: COMPLETED ·Phase: NA
-
Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
NCT06157567 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
NCT06202274 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow
NCT04969380 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Efficacy and Safety of the Skinstylus Sterilock Microneedling System for the Treatment of Facial Wrinkles
NCT06032286 ·Status: COMPLETED ·Phase: NA
-
Prospective Clinical Study to Assess Safety and to Collect Data on Radiofrequency Microneedling Device(s) For the Purpose of Evaluating Treatment on Skin
NCT06023303 ·Status: COMPLETED ·Phase: NA
-
Renuvion APR Device to Improve the Appearance of Lax Tissue in the Neck and Submental Region
NCT04146467 ·Status: COMPLETED ·Phase: NA
-
Clinical Study to Evaluate the Performance of Fractional Radiofrequency for Improvement of Skin Texture Via Skin Resurfacing and Wrinkles Reduction
NCT00887913 ·Status: COMPLETED ·Phase: NA
-
Sculptra for Décolletage Crepiness and Wrinkling
NCT03508973 ·Status: COMPLETED ·Phase: NA
-
Performance of the ePrime System for Cellulite
NCT02489994 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness and Safety of the Octave System for Lifting the Eyebrow and Improving the Appearance of the Face and Neck
NCT05067504 ·Status: COMPLETED ·Phase: NA
-
Treatment of Moderate to Severe Lateral Canthal Lines
NCT04249687 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Effectiveness Evaluation of the Device in Achieving Submental Lift
NCT02832674 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Ulthera® System for Treatment of the Face and Neck
NCT01713907 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy of the EndyMed Pro System Using RF Micro-needles Fractional Skin Remodeling
NCT02368626 ·Status: UNKNOWN ·Phase: NA
-
Treatment to Lift Facial Lax Skin and Improve Facial Wrinkles Using Precise and Lift Applicators
NCT06333067 ·Status: RECRUITING ·Phase: NA
-
Clinical Study to Evaluate Different Energy-based Devices for Aesthetic Treatments.
NCT06111482 ·Status: RECRUITING ·Phase: NA
-
Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I
NCT02677298 ·Status: COMPLETED ·Phase: PHASE3
-
Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions
NCT05987319 ·Status: RECRUITING ·Phase: NA
-
Lutronic Genius System for Neck Treatment
NCT03534609 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Efficacy and Safety of the triLift™ System
NCT05773924 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy Study of PurTox® Botulinum Toxin Type A to Treat Frown Lines Between the Eyebrows
NCT00752297 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Four Injectable Neuromodulators in the Glabella Area Glabella Area
NCT05167864 ·Status: COMPLETED ·Phase: NA
-
MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines
NCT03732833 ·Status: COMPLETED ·Phase: PHASE3